New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For WES;ALDW;ABBV;WHF;WGP;ALJ;LRCX;FB;ABT From The Last 14 Days
Check below for free stories on WES;ALDW;ABBV;WHF;WGP;ALJ;LRCX;FB;ABT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 27, 2014
06:04 EDTFBSnapchat's valuation hits $10B, WSJ reports
Subscribe for More Information
05:54 EDTFBFacebook says did not acquire WaveGroup Sound, VentureBeat reports
Subscribe for More Information
August 26, 2014
11:55 EDTFBInstagram announces Hyperlapse from Instagram app
Instagram announced on its blog Hyperlapse from Instagram, "a new app to capture high-quality time lapse videos even while in motion. Traditionally, time lapse videos depend on holding your phone or camera still while you film. Hyperlapse from Instagram features built-in stabilization technology that lets you create moving, handheld time lapses that result in a cinematic look, quality and feel—a feat that has previously only been possible with expensive equipment." Reference Link
09:35 EDTFBActive equity options trading on open
Subscribe for More Information
August 25, 2014
13:06 EDTFBWhatsApp grows to 600M monthly active users
Subscribe for More Information
August 24, 2014
21:56 EDTLRCXB. Riley to hold a tour
Silicon Valley Tech Tour travels throughout Silicon Valley on August 25-27.
August 21, 2014
15:16 EDTABBVDEA restricts painkiller drug prescriptions to curb abuse, WSJ reports
The Drug Enforcement Agency, or DEA, will reclassify hydrocodone combination painkiller drugs and place them in the category of medical substances that have the highest potential for harm in an attempt to curb the widespread abuse of the drugs, according to The Wall Street Journal. The rescheduling of the drugs will take effect in 45 days and result in people being able to obtain the drug for only 90 days without obtaining a new prescription. Major manufacturers of these drugs include Teva Pharmaceutical (TEVA), Mallinckrodt (MNK), AbbVie (ABBV), and Actavis (ACT). Reference Link
12:59 EDTFBPrivacy lawsuit against Facebook draws support from 60,000 users, Reuters says
A class action lawsuit against Facebook Ireland, the division that runs the company's international business activities, has received support from more than 60,000 users and passed its first legal review, Reuters reports, citing the creator of the lawsuit, Australian law student Max Schrems. The lawsuit claims damages of $663 per Facebook user for alleged privacy violations. The Vienna Regional Court has ordered Facebook Ireland to respond to the claims made by the lawsuit within four weeks, Schrems added. Reference Link
07:57 EDTABBVGilead HCV risks overblown, says Bernstein
Bernstein believes that investors are concerned about upcoming competition to Gilead's (GILD) HCV drug from AbbVie's (ABBV) HCV treatment. But Bernstein says that insurers can only prevent 16% of the U.S. population from receiving Gilead's drug, and the firm does not expect the HCV market share dynamics to change in the near-term. It keeps an Outperform rating on Gilead.
August 20, 2014
09:36 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL FOLD TSLA TWTR WHX FB TM NFLX X EOG
August 19, 2014
09:38 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD TSLA CELG VLO VZ FB HD
07:09 EDTALDWCitigroup to hold a conference
MLP / Midstream Infrastructure Conference to be held in Las Vegas on August 19-21.
August 18, 2014
09:35 EDTFBActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AMZN DG TSLA GILD FB ABX WFC C
09:20 EDTFBFacebook Q3 North American revenue tracking slightly above, says ITG Research
ITG Research said Facebook's Q3 North American revenue is tracking to $1.45B vs. consensus of $1.4B.
09:00 EDTABTAbbott and Defense Department to develop portable blood tests
Subscribe for More Information
06:47 EDTFBFacebook volatility at low end of historic range
Subscribe for More Information
August 15, 2014
13:35 EDTFBFacebook July metrics remain strong, says JPMorgan
Subscribe for More Information
11:42 EDTLRCXApplied Materials rises following strong profit, gross margin, order growth
Shares of semiconductor equipment maker Applied Materials (AMAT) are advancing after posting strong third quarter profit, adjusted gross margin, and order growth. WHAT'S NEW: Last night, Applied Materials reported Q3 adjusted earnings per share of 28c and revenue of $2.27B, compared to analysts’ consensus estimates of 27c and $2.29B, respectively. Q3 adjusted gross margin came in at 45.5%, up 260 basis points year-over-year, and up 130 basis points sequentially. Q3 orders of $2.48B, increased 24% year-over-year led by SSG year-over-year order growth of $362M. President and CEO Gary Dickerson said, “We have focused our strategy and investments in areas that have the largest impact for customers while driving improvements in execution and speed across the company. With these actions, we have improved our operating margins for seven quarters in a row and are making substantial progress towards our long-term financial model." WHAT’S NOTABLE: For the fourth quarter, Applied Materials expects adjusted EPS of 25c-29c, versus consensus of 26c. Q4 revenue is expected to be approximately flat, plus or minus 3% sequentially, and up by approximately 10%-17% from the year-ago period, compared to consensus of $2.28B. PRICE ACTION: In late morning trading, Applied Materials rose $1.04, or about 5%, to $22.19 on heavy trading volume. Including today’s advance, the stock has gained approximately 45% over the past twelve months. OTHERS TO WATCH: Other companies in the semiconductor equipment space include Lam Research (LRCX), Kulicke and Soffa (KLIC), and KLA-Tencor (KLAC).
07:25 EDTFBFacebook Messenger said to receive harsh criticism, FT reports
Subscribe for More Information
06:00 EDTFBFacebook's Sam Lessin leaving company, Business Insider reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use